1.Autopsy on medical dispute cases.
Chinese Journal of Pathology 2009;38(6):361-362
3.Trends in pathology research of liver tumors.
Chinese Journal of Pathology 2007;36(11):721-722
Angiomyolipoma
;
pathology
;
Bile Duct Neoplasms
;
pathology
;
virology
;
Bile Ducts, Intrahepatic
;
Carcinoma, Hepatocellular
;
pathology
;
virology
;
Carcinosarcoma
;
pathology
;
Cholangiocarcinoma
;
pathology
;
virology
;
Hepatitis B
;
Hepatitis C
;
Humans
;
Liver Neoplasms
;
pathology
;
virology
;
Pathology, Clinical
;
trends
6.Updates on biologic function of tumor suppressor gene inhibitor of growth family and related studies.
Chinese Journal of Pathology 2009;38(12):859-861
Animals
;
Apoptosis
;
Cell Cycle
;
Cell Cycle Proteins
;
genetics
;
metabolism
;
physiology
;
DNA Repair
;
Homeodomain Proteins
;
genetics
;
metabolism
;
physiology
;
Humans
;
Inhibitor of Growth Protein 1
;
Intracellular Signaling Peptides and Proteins
;
genetics
;
metabolism
;
physiology
;
Neoplasm Metastasis
;
Neoplasms
;
metabolism
;
pathology
;
Neovascularization, Pathologic
;
pathology
;
Nuclear Proteins
;
genetics
;
metabolism
;
physiology
;
Prognosis
;
Receptors, Cytoplasmic and Nuclear
;
genetics
;
metabolism
;
physiology
;
Signal Transduction
;
Transcription Factors
;
genetics
;
metabolism
;
physiology
;
Tumor Suppressor Protein p53
;
metabolism
;
Tumor Suppressor Proteins
;
chemistry
;
genetics
;
metabolism
;
physiology
10. Effects of fructopyrano-(1 → 4)-glucopyranose extracted from Radix Isatidis on tumor growth and immune function in tumor-bearing mice
Chinese Pharmaceutical Journal 2012;47(19):1542-1546
OBJECTIVE: To study the effects of fructopyrano-(1 → 4)-glucopyranose (FG) extracted from Radix Isatidis on the tumor growth and immune activity in tumor-bearing mice. METHODS: The antitumor activity of FG in vivo was observed by implanted H22 and S180 mouse models. The effect of FG on immune function in tumor-bearing mice was investigated by using phagocytosis test, T plymphocyte proliferation test, and Elisa for determining the expression levels of TNF-α, IL-2, IL-6, and IL-12. RESULTS: At dosages of 50, 100 and 200 mg · kg-1, the inhibition rates of FG were 23.60%, 36.76% and 49.26% for S180, 22.61%, 36.52%, and 46.95% for H22, respectively. FG increased the spleen index and chest gland index, improved the phagocytosis function of the macrophage and enhance the T lymphocytes proliferation, and increased the expression levels of TNF-α, IL-2, IL-6, and IL-12. CONCLUSION: FG exhibits significant anti-tumor effect in vivo and the mechanism may be related to enhancing immune function. Copyright 2012 by the Chinese Pharmaceutical Association.